Zhejiang Shengda Pharm603079
▲ PositiveCapitalrelevance
Company completed first share buyback, signaling confidence and supporting share price.

Shengda Biotech completed its first buyback of 180,000 shares through centralized bidding, representing 0.10% of total share capital. The buyback amount was 1.99 million yuan, with a price range of 10.71 yuan to 10.86 yuan per share. In the first quarter of 2026, the company achieved revenue of 189 million yuan and net profit attributable to shareholders of 13.17 million yuan.
Zhejiang Shengda PharmCompany completed first share buyback, signaling confidence and supporting share price.